Abstract
This paper reviews recent research on the contribution of the proinflammatory cytokine interleukin-1β (IL-1β) and the purine nucleoside adenosine in mediating behavioral depression and related symptoms of conservation-withdrawal in animal models of traumatic stress, major depression, and illness. Activation of brain IL-1β receptors appears to contribute to conservation-withdrawal by exacerbating the immediate impact of a stressor or by enhancing and prolonging the overall reaction. Moreover, brain cytokine signaling is capable of recruiting adenosine signaling at A2A, which directly mediates symptoms of behavioral depression. The adenosine receptors densely populate spiny GABAergic neurons in the striopallidal tract in the striatum and form part of an A2A/D2/mGLU receptor complex. Activation of these A2A receptors functionally uncouples dopamines excitatory motivation influence on ongoing behavior, leading to a state of conservation- withdrawal.
Keywords: ATP, Adenosine receptors, adenosine receptor antagonists, shock, Reserpine, DMSO
CNS & Neurological Disorders - Drug Targets
Title: Cytokine-Purine Interactions in Traumatic Stress, Behavioral Depression,and Sickness
Volume: 5 Issue: 5
Author(s): Thomas R. Minor, Qingjun Huang and Alexis E. Witt
Affiliation:
Keywords: ATP, Adenosine receptors, adenosine receptor antagonists, shock, Reserpine, DMSO
Abstract: This paper reviews recent research on the contribution of the proinflammatory cytokine interleukin-1β (IL-1β) and the purine nucleoside adenosine in mediating behavioral depression and related symptoms of conservation-withdrawal in animal models of traumatic stress, major depression, and illness. Activation of brain IL-1β receptors appears to contribute to conservation-withdrawal by exacerbating the immediate impact of a stressor or by enhancing and prolonging the overall reaction. Moreover, brain cytokine signaling is capable of recruiting adenosine signaling at A2A, which directly mediates symptoms of behavioral depression. The adenosine receptors densely populate spiny GABAergic neurons in the striopallidal tract in the striatum and form part of an A2A/D2/mGLU receptor complex. Activation of these A2A receptors functionally uncouples dopamines excitatory motivation influence on ongoing behavior, leading to a state of conservation- withdrawal.
Export Options
About this article
Cite this article as:
Minor R. Thomas, Huang Qingjun and Witt E. Alexis, Cytokine-Purine Interactions in Traumatic Stress, Behavioral Depression,and Sickness, CNS & Neurological Disorders - Drug Targets 2006; 5 (5) . https://dx.doi.org/10.2174/187152706778559282
DOI https://dx.doi.org/10.2174/187152706778559282 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Use of Total Parenteral Nutrition in Severe Anorexia Nervosa Complicated by a Gastrointestinal Illness
Current Nutrition & Food Science Levosimendan: A New Inodilatory Drug for the Treatment of Decompensated Heart Failure
Current Pharmaceutical Design The Heart in Sepsis: From Basic Mechanisms to Clinical Management
Current Vascular Pharmacology The Role of Mitochondrial Function in Glutamate-Dependent Metabolism in Neuronal Cells
Current Pharmaceutical Design Neuromodulation of the Perinatal Respiratory Network
Current Neuropharmacology What Fans the Fire: Insights into Mechanisms of Leptin in Metabolic Syndrome- Associated Heart Diseases
Current Pharmaceutical Design The Importance of Early Diagnosis and Treatment in Peripheral Arterial Disease: Insights from the PARTNERS and REACH Registries
Current Vascular Pharmacology Medication-Induced Nephrotoxicity in Older Patients
Current Drug Metabolism Editorial (Thematic Issue: Modifying Cardiovascular Risk Factors: Newer Advances in Cardiovascular Metabolism and Diagnostic Technologies)
Current Pharmaceutical Design Advancement in Obesity Management: Leptin and Adiponectin Patents
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Levosimendan: A Novel Agent in Heart Failure
Recent Patents on Cardiovascular Drug Discovery Endothelin Receptor Antagonists: A New Therapeutic Option for Improving the Outcome after Solid Organ Transplantation?
Current Vascular Pharmacology Critical Illness in Obstetric Patients: Introduction and Epidemiology
Current Women`s Health Reviews The Guanylyl Cyclase Inhibition by MB as Vasoplegic Circulatory Shock Therapeutical Target
Current Drug Targets Surgical Ventricular Restoration: An Operation to Reverse Remodeling - Clinical Application (Part II) (Supplementry Table)
Current Cardiology Reviews Paracrine Mechanisms Involved in Mesenchymal Stem Cell Differentiation into Cardiomyocytes
Current Stem Cell Research & Therapy Defective Autophagy in Fibroblasts May Contribute to Fibrogenesis in Autoimmune Processes
Current Pharmaceutical Design The Fundamental Role of Stress Echo in Evaluating Coronary Artery Disease in Specific Patient Populations
Current Vascular Pharmacology Serum Specific Vasopressin-Degrading Activity is Related to Blood Total Cholesterol Levels in Men but not in Women
Medicinal Chemistry Effects of Static Magnetic Fields on Blood Pressure in Animals and Humans
Current Hypertension Reviews